• Founded in March 2014
  • Established by a group of third-grade class-A hospitals, medical colleges, drug research institutes, pharmaceutical enterprises, CRO and SMO companies, medical insurance institutions, software enterprises and industrial KOLs
  • Registered by Beijing Registration and Management Social Association as a non-profit social organizations
  • Predecessor academic salon of China GCP founded in October 2012
  • Class I union that carried out activities nationwide

DEVELOPMENT

  • 2012

    China GCP Salon founded

  • 2013

    China GCP Union founded & preparing for Zhongguancun Industry Alliance

  • 2014

    ZHONGGUANCUN JIUTAI GOOD CLINICAL PRACTICE UNION founded

    Standard System Construction on drug clinical trials/industry studies implemented

    Official website/Wechat public number opened

  • 2015

    Held cross-strait“On-site Academic Exchange on Drug Clinical Trials Management”

    Launched the platform of clinical study service and established the big data platform on pharmacogenomics

    Implementation of auxiliary tool of drug clinical trials management

  • 2016

    Released “Field Evaluation Standards on Centralized Management of Drug Clinical Study”

    Delegation visited US,developing nationalized cooperation and exchange

    Collaborating with the Alliance members,obtained 2 projects’ support on“Precision Medicine Research”of National Key R&D Program

    Visited Italy for ITALY-CHINA SCIENCE, TECHNOLOGY AND INNOVATION WEEK

  • 2017

    Registration on“NATIONAL ORGANIZATION STANDARD INFORMATION PLATFORM“

    Released “Industry Guidebook for CRC”

    Initiation of developing “ Industry Guideline for China CRO Management”

    Started the building of training platform

    Collaborating with the Alliance members obtained 8 projects of New Drug Innovation Platform, and 1 project of key R&D program about Chronic non-communicable diseases

  • 2018

    A general election and new leadership group confirmation

    Establishment of Committee on clinical study of cell therapy& biological agents

    Attended 2018 World Life Science Conference and co-organizer of 2020 World Life Science Conference

AIMS

Based on upstream and downstream industry chain,promoting new technology

for novel commercialization by setting new standards to build

a new form of industrial organization integrated system of production, teaching

and research, cross-border integration , collaborative innovation.

BLUEPRINT

STRATEGIC COOPERATION

Collaborative innovation on multi-organizational,

boost resource conformity, knowledge sharing , rule exploration , enhancing industry vitality

UNION LEADERSHIP

Chairman

Wang Xiaoning

Chinese PLA General Hospital for Geriatrics, Director& Professor

Constantly strives to research on technology strategy, participates in lots of planning and surveillance of national science and technology projects.

Published over 70 articles on SCI Indexed Journals such as Science, Nat Med, Nat Biotech, Cell Res,and is cited more than 1200 times;

Won one first prize in National Teaching Achievement Award, one second prize in National Science and Technology Progress Award,two first prizes & five second prizes in provincial and ministerial level Teaching Achievement Award .

Former Deputy director of CFDA Certification Management Center

Vice-Chairman of Drug Clinical Trial Professional Committee of CPS

Expert reviewer of the National Technology Invention Prize and technology advancement prize

Responsible expert in National Science and Technology Major Projects for "Major New Drugs Innovation and Development" of the Chinese Ministry of Science and Technology

Financial acceptance expert of National Science and TechnologyMajor Projects , National Science and Technology Major Projects of the National Health and Family Planning Commission

Member of committee on assessment of the protected traditional Chinese medicinal products of CFDA

Evaluation expert in Drug evaluation center of National Development and Reform Commission

Evaluation expert in Investment Assessment Center of PRC Minister of Finance

Expert in EML Group of drug administration of National Health Commission

Secretary

Cao Cai

MEMBERS

Up to April 2019, 226 Alliance members.

SERVICE SCOPE

CLINICAL STUDY SERVICE

TRAINING PLATFORM

To improve the overall quality of Chinese clinical study industry, gathering many authoritative experts and scholars on the front line from third-grade class-A hospitals,based on self-developed training platform,with various multidimensional professional trainings such as offline training, symposium, academic salon, industry forum, online education.
With high-level teachers and scientific training systems ,providing large quantities of training resources,such as:

Online GCP training—qualification for drug clinical trial institution, inspection review, simulation inspection、 continuing education(before 2018);

Promotion of vocational skills—cooperate with first-class universities and institutions at home and abroad, hold vocational skills training and qualification improvement for all kinds of personnel in the clinical study such as PI、CRC、CRA;

Live broadcasting on industry conferences;

KOL lectures and high-end academic salon.

Online Training Platform

Online Training
Video meeting

STANDARD SETTING

Developing and promoting practical guidelines and standards of Good Clinical Practice, build and optimize innovative drugs and innovative technology environment,promoting the standardized development of industry. To date,the Union has completed the registration on“NATIONAL ORGANIZATION STANDARD INFORMATION PLATFORM“, released 2 Union standards as“ Industry Guidebook for CRC”、“Field Evaluation Standards on Centralized Management of Drug Clinical Study”,conducted research about “Quality Control and Management Standards of Cell Therapy”.

PROFESSIONAL CONSULTING SERVICE

Provide professional consulting service to our members and society; focus on industrial key research directions,organize prospective study on industry trends,provide advices for national formulation and improvement of relevant policies and regulations.

INTERNATIONAL EXCHANGE AND COOPERATION

By participation and organization of various international academic exchanges, actively implementing the "Going Out" strategy,seeking more opportunities for cooperation with international academic organizations ,combining industrial needs and characteristics of clinical study, actively introducing international advanced technical standards and innovation mechanisms,connecting international and advanced management practice.

VISION AND MISSION

Observer in drug clinical trials
Proposer of industry consensus
Innovator on the advanced technology

中关村玖泰药物临床试验技术创新联盟版权所有 京ICP备16027906号-1 京公网安备110102021259号